about
Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokineticsCharacterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolamDetection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokineticsSeparation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopy.Activation of the pro-migratory bone morphogenetic protein receptor 1B gene in human MDA-MB-468 triple-negative breast cancer cells that over-express CYP2J2.Flubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepine.Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency.Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8.Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.Finding cannabinoids in hair does not prove cannabis consumption.Designer benzodiazepines: A new challenge.Reply to 'Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA'.In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability.Cannabinoid findings in children hair - what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9-tetrahydrocannabinolic acid A concentrations.Reply to Restolho et al. 'Contactless decontamination of hair samples: cannabinoids'.Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and itsHair analysis for Δ(9) -tetrahydrocannabinolic acid A (THCA-A) and Δ(9) -tetrahydrocannabinol (THC) after handling cannabis plant materialLC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windowsStability of 11 prevalent synthetic cannabinoids in authentic neat oral fluid samples: glass versus polypropylene containers at different temperaturesCharacteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolismMetabolites of synthetic cannabinoids in hair--proof of consumption or false friends for interpretation?A fast and inexpensive procedure for the isolation of synthetic cannabinoids from 'Spice' products using a flash chromatography systemCharacterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864)
P50
Q28235472-373BD0C4-B748-4CC5-A9A6-6D4500029F40Q28277912-E60FC070-99F0-4C29-9A86-2C36515C315FQ28302395-208DC109-5CE0-4D05-8430-8FB6D0FCE31DQ34530742-F91D21A5-2949-4824-A90D-68FAD8BD1EDCQ38441033-395469E6-952A-4DEF-AA90-1A5EBA107C51Q38853831-9FB8825F-7654-4AF6-8455-3A61BD7CC42FQ38858777-7483B846-634C-4CE2-8A71-3BA071A88EBCQ38994109-CD87699F-748C-41F2-BC55-BE9D2D7BE6ACQ39009725-A923BC07-8D96-4338-952C-6AA867B451D5Q39508464-B6F66E77-0670-4E15-8C0D-2FDAE8BB014DQ40459231-25F91633-9B63-4C63-A8D4-F6620B0A51E9Q42425129-86FAC4EB-2DA9-4CEA-8C2B-6717FECBAE1AQ42751396-5E967A29-DA15-4888-BA38-6E646F3202EBQ46594306-86EE5380-E467-4F00-AE38-922611A83EF1Q52874997-6D2EA852-3411-42A6-B9F7-9148842F2BC2Q54288865-F5F65AC7-EDBD-4DD9-BEF9-5736462293B9Q56532320-B4D54E10-A6F0-48B2-8329-FB3A99849127Q59664462-D9BA48E4-5B0E-4321-B5B4-16533A1F370CQ85419855-ABE50204-30E6-4FBB-AFDC-15E9DF1EA315Q86499164-D06F4271-03DD-4612-A8E0-4526363BA5F6Q86848115-0D8635BE-40E4-4B83-B76A-12C3A6891436Q87056128-7B0D02B5-88DC-410C-910A-FBF69A6B86EEQ87402638-B3F5DB55-CF31-4DF7-A74D-CC178F21AF9EQ87441749-8F4178CB-2945-4C08-837B-A9B3A674A5F1Q90713993-B1FD2D80-2DF0-4DCE-83AE-EA7D9DF33816
P50
description
onderzoeker
@nl
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Bjoern Moosmann
@en
Bjoern Moosmann
@es
Bjoern Moosmann
@nl
Björn Moosmann
@de
type
label
Bjoern Moosmann
@en
Bjoern Moosmann
@es
Bjoern Moosmann
@nl
Björn Moosmann
@de
prefLabel
Bjoern Moosmann
@en
Bjoern Moosmann
@es
Bjoern Moosmann
@nl
Björn Moosmann
@de
P227
P106
P214
92144782945551167586
P227
1077930755
P31
P496
0000-0003-1757-6359
P569
1984-01-01T00:00:00Z
P7859
viaf-92144782945551167586